设为首页 电子邮箱 联系我们

本刊最新招聘信息请见“通知公告”!  本刊投稿系统试运行中,欢迎投稿!如投稿有问题,可直接将稿件发送至zgyy8888@163.com

 

主管单位:中华人民共和国   

国家卫生健康委员会

主办单位:中国医师协会
总编辑:
杨秋

编辑部主任:吴翔宇

邮发代号:80-528
定价:28.00元
全年:336.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)

                  

过刊目录

2020 年第 1 期 第 15 卷

替罗非班联合尼可地尔对ST段抬高型心肌梗死急诊经皮冠状动脉介入患者炎性反应和心功能的影响

Effect of tirofiban combined with nicorandil treating acute ST-segment elevation myocardial infarction patients undergoing emergency percutaneous coronary intervention on inflammatory response and cardiac function

作者:刘春丽梁延宏薛恩忠贺继忠

英文作者:

单位:陕西省延安市人民医院心血管内科716000

英文单位:

关键词:ST段抬高型心肌梗死;替罗非班;尼可地尔;经皮冠状动脉介入;炎症因子

英文关键词:

  • 摘要:
  • 【摘要】目的    探讨替罗非班联合尼可地尔对ST段抬高型心肌梗死(STEMI)患者经皮冠状动脉介入(PCI)治疗术后血清炎症因子和心功能的影响。方法    选择2016年1月至2018年5月在陕西省延安市人民医院住院行PCI治疗的STEMI患者120例,采用随机数字表法分为对照组和观察组,各60例,对照组介入术中术后给予替罗非班治疗,观察组介入术中术后给予替罗非班联合尼可地尔治疗。比较2组患者PCI前后血清炎症因子高敏C反应蛋白(hs-CRP)、肿瘤坏死因子α(TNF-α)和白细胞介素6(IL-6)水平,术后不同时点心功能指标左心室舒张末期容积(LVEDV)、左心室射血分数(LVEF)和舒张早期与舒张晚期二尖瓣血流速度比值(E/A)以及术后随访90 d内主要不良心血管事件和治疗期间出血事件发生率。结果    观察组术后24 h血清IL-6水平和术后7 d血清hs-CRP、TNF-α、IL-6水平均低于对照组[(7.6±1.9)ng/L比(8.6±1.8)ng/L、(5.3±0.8)mg/L比(8.6±1.1)mg/L、(159±34)ng/L比(211±43)ng/L、(3.0±1.2)ng/L比(3.7±1.2)ng/L],差异均有统计学意义(均P<0.05)。术后90 d,观察组LVEDV显著小于对照组[(85±9)ml比(92±9)ml],LVEF和E/A高于对照组[(60±5)%比(56±6)%、(1.2±0.3)比(0.9±0.3)],差异均有统计学意义(均P<0.05)。与术后24 h比较,2组术后90 d LVEDV均显著增大,LVEF和E/A均明显降低,差异均有统计学意义(均P<0.05)。2组术后90 d内主要不良心血管事件发生率和治疗期间出血事件发生率比较差异均无统计学意义(P=0.327、1.000)。结论    对于STEMI患者,尼可地尔联合替罗非班较单用替罗非班能有效降低PCI术后急性期内血清炎症因子水平、保护左心室功能。

  • 【Abstract】Objective    To investigate the clinical effect of tirofiban combined with nicorandil on acute ST-segment elevation myocardial infarction(STEMI) patients undergoing percutaneous coronary intervention(PCI) and the effect on serum inflammatory factors and cardiac function. Methods    A total of 120 patients with STEMI undergoing PCI in Yan′an People′s Hospital, Shaanxi Province from January 2016 to May 2018 were randomly divided into control group(60 cases) treated with tirofiban and observation group(60 cases) treated with tirofiban plus nicorandil. Serum levels of high-sensitivity C-reactive protein(hs-CRP), tumor necrosis factor-α(TNF-α) and interleukin-6(IL-6) were detected before and after PCI. Left ventricular end-diastolic volume(LVEDV), left ventricular ejection fraction(LVEF) and mitral early diastolic filling velocity(E)/late diastolic filling velocity(A) ratio were monitored at different time points after PCI. Main adverse cardiovascular events(MACE) within 90 days after procedure and bleeding events during treatment were observed. Results    Serum levels of IL-6 at 24 h after PCI, hs-CRP, TNF-α and IL-6 at 7 d after PCI in observation group were significantly lower than those in observation group[(7.6±1.9)ng/L vs (8.6±1.8)ng/L, (5.3±0.8)mg/L vs (8.6±1.1)mg/L, (159±34)ng/L vs (211±43)ng/L, (3.0±1.2)ng/L vs (3.7±1.2)ng/L](all P<0.05). At 90 d after PCI, LVEDV in observation group was significantly lower and LVEF, E/A ratio were higher than those in control group[(85±9)ml vs (92±9)ml, (60±5)% vs (56±6)%, (1.2±0.3) vs (0.9±0.3)](all P<0.05). LVEDV increased and LVEF, E/A decreased at 90 d in both groups compared with those at 24 h after PCI(all P<0.05). There were no statistical differences in the 90 d MACE and bleeding events between groups(P=0.327, P=1.000). Conclusion    Tirofiban combined with nicorandil treating STEMI patients can significantly reduce inflammation and protect left ventricular function after PCI.

copyright 《中国医药》杂志编辑部
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址:www.chinamedicinej.com 京ICP备2020043099号-3

当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。







安卓


苹果

关闭